Yang Xu

Targeting Radiation-Induced G2 Checkpoint Activation with the Wee-1 Inhibitor MK-1775 in Glioblastoma Cell Lines

Bhaswati Sarcar, Soumen Kahali, Antony Prabhu et al. · Molecular Cancer Therapeutics · 2011 · 105 citations · Full text

Inhibition of capsaicin‐induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK‐0974)

Simon Sinclair, Stefanie A. Kane, Bart Van der Schueren et al. · British Journal of Clinical Pharmacology · 2009 · 85 citations · Full text

Single‐Dose Administration of MK‐0657, an NR2B‐Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease

Carol Addy, C. Assaid, David Hreniuk et al. · The Journal of Clinical Pharmacology · 2009 · 61 citations

Nr2b‐selective Nmda Antagonist, Neurological Progress, Clinical Neuroscience +17

Pharmacokinetics of Ertapenem in Patients With Varying Degrees of Renal Insufficiency and in Patients on Hemodialysis

Goutam C. Mistry, Anup Majumdar, Suzanne K. Swan et al. · The Journal of Clinical Pharmacology · 2006 · 49 citations

Single‐ and Multiple‐Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene‐Related Peptide Receptor Antagonist, in Adults

Tae Hyung Han, Rebecca Blanchard, John Palcza et al. · The Journal of Clinical Pharmacology · 2010 · 34 citations

Acute Treatment, Therapeutic Drug Monitoring, Medicinal Chemistry +12